BioCryst Pharmaceuticals (BCRX): Q3 EPS of -$0.19 beats by $0.02. Revenue of $5.8M (+11.5% Y/Y)...

|About: BioCryst Pharmaceuticals... (BCRX)|By:, SA News Editor
BioCryst Pharmaceuticals (BCRX): Q3 EPS of -$0.19 beats by $0.02. Revenue of $5.8M (+11.5% Y/Y) beats by $1.2M. (PR)